Analysis of Glycemic Control and Low-Density Lipoprotein Cholesterol with Glaucomatous Optic Neuropathy as a Microvascular Complication in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study in North Sumatera, Indonesia
DOI:
https://doi.org/10.3889/oamjms.2021.6325Keywords:
Type 2 Diabetes Mellitus, HbA1c, LDL Cholesterol, Glaucomatous Optic NeuropathyAbstract
BACKGROUND: Diabetes mellitus (DM) is an important health problem that induces microvascular complication such as retinopathy, nephropathy, and neuropathy. Ocular complications associated with type 2 DM are progressive and rapidly becoming the world’s most significant cause of morbidity and preventable with early detection and timely treatment.
AIM: This study to analyze of glycemic control and low-density lipoprotein cholesterol (LDL-C) with glaucomatous optic neuropathy as a microvascular complication in patients with type 2 DM.
MATERIALS AND METHODS: A prospective, analytical observational with cross-sectional study was conducted in Universitas Sumatera Utara Hospital and Satellite Hospital, Medan, Indonesia, from April 2020 to August 2020. The study included 66 participants with type 2 DM. The patients were investigated for hemoglobin A1c (HbA1c) level, LDL-C level, and ophthalmology examination including visual acuity (VA), intraocular pressure (IOP) measurement by Goldmann Applanation Tonometer, retinal nerve fiber layer (RNFL) thickness with spectral domain Optovue optical coherence tomography, and visual field defect with Octopus Perimeter.
RESULTS: This study showed a significant correlation between HbA1c with VA (p = 0.030), IOP (p = 0.035), RNFL thickness (p = 0.002), visual field defect (p = 0.032), and duration of DM (p = 0.003) and showed significant correlation between LDL-C with VA (p = 0.048), IOP (p = 0.006), and duration of DM (p = 0.042).
CONCLUSION: Higher HbA1c and LDL-C correlated with Glaucomatous Optic Neuropathy as a microvascular complication in type 2 DM. Advantage of research is still rarely studied.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Nanditha A, Ronald CW, Ramachandran A, Snehalatha C, Chan JC, Chia KS, et al. Diabetes in Asia and the pacific: Implications for the global epidemic. Diabetes Care J. 2016;39(3):472-85. https://doi.org/10.2337/dc15-1536 PMid:26908931 DOI: https://doi.org/10.2337/dc15-1536
Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes. 2015;6(1):92-108. PMid:25685281 DOI: https://doi.org/10.4239/wjd.v6.i1.92
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31(1):562-7. DOI: https://doi.org/10.2337/dc08-S055
International Diabetes Federation. Diabetes Facts and Figures. IDF Diabetes Atlas 9th ed. Belgium: International Diabetes Federation; 2019. https://doi.org/10.1016/s1499-2671(08)24263-2 DOI: https://doi.org/10.1016/S1499-2671(08)24263-2
Perkumpulan Endokrinologi Indonesia. Konsensus Pengendalian dan Pencegahan Diabetes Mellitus Tipe 2 di Indonesia. Perkeni, Jakarta: Perkumpulan Endokrinologi Indonesia; 2016.
Aiello LP, Alejandro R, Alsahli M, Atkinson MA, Bode BW, Skyler JS, et al. Atlas of Diabetes. 4th ed. Miami: Springer; 2012. p. 249-75.
Cantor LB, Rapuano CJ, Cioffi GA, editors. Association Glaucoma Section 10th. Introduction to Glaucoma: Terminology, Epidemiology, and Heredity. San Fransisco: American Academy of Ophthalmology the Eye MD; 2016. p. 20.
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262-7. PMid:16488940 DOI: https://doi.org/10.1136/bjo.2005.081224
Kemenkes RI. Situasi dan Analisis Glaukoma: Pusat Data Dan Informasi Kementerian Kesehatan RI. Jakarta: Kemenkes RI; 2015. https://doi.org/10.32922/jkp.v8i2 DOI: https://doi.org/10.32922/jkp.v8i2
Riset Kesehatan Dasar. Gangguan Penglihatan dan Kebutaan di Indonesia. Badan Penelitian dan Pengembangan Kesehatan. Jakarta: Riset Kesehatan Dasar; 2007. https://doi.org/10.22435/jpppk.v3i1.1882 DOI: https://doi.org/10.22435/jpppk.v3i1.1882
Song JB, Aiello LP, Pasquale LR. Presence and risk factors for glaucoma in patients with diabetes. Curr Diab Rep. 2016;16(12):124. https://doi.org/10.1007/s11892-016-0815-6 PMid:27766584 DOI: https://doi.org/10.1007/s11892-016-0815-6
Choi JA, Park YM, Han K, Lee J, Yun JS, Ko SH. Fasting plasma glucose level and the risk of open angle glaucoma: Nationwide population-based cohort study in Korea. PLoS One. 2020;9(23):e0239529. https://doi.org/10.1371/journal.pone.0239529 PMid:32966328 DOI: https://doi.org/10.1371/journal.pone.0239529
Pimentel LG, Gracitelli CP, da Silva LS, Souza AK, Prata TS. Association between glucose levels and intraocular pressure: Pre-and post-prandial analysis in diabetic and nondiabetic patients. J Ophthalmol. 2015;2015:832058. https://doi.org/10.1155/2015/832058 PMid:25642344 DOI: https://doi.org/10.1155/2015/832058
Dube M, Chhawania PK, Shukla A, Kujur R. Correlation between serum lipids and primary open angle glaucoma: A clinical study. Delhi J Ophthalmol 2019;29:58-60. https://doi.org/10.7869/djo.444 DOI: https://doi.org/10.7869/djo.444
Aref AA, Budenz DL. Spectral domain optical coherence tomography in the diagnosis and management of glaucoma. Ophthalmic Surg Lasers Imaging 2010;41:15-27. https://doi.org/10.3928/15428877-20101031-01 DOI: https://doi.org/10.3928/15428877-20101031-01
Khan MA, Rabeya MR, Saeidullah M. Measurements of HbA1c by high performance liquid chromatography in D-10 analyzer and immunological method by Beckman coulter AU480 system: A comparative study. J Enam Med Coll. 2012;2(2):62-6. https://doi.org/10.3329/jemc.v2i2.12839 DOI: https://doi.org/10.3329/jemc.v2i2.12839
National Cholesterol Education Program. ATP III Guidelines at-a-Glance Quick Desk Reference. United States: Department of Health and Human Services; 2001.
Prabavathi K, Kunilkullaya KU, Goturu J. Glycosilated haemoglobin (HbA1c) a marker of circulating lipids in Type 2 diabetic patients. J Clin Diagn Res. 2014;8(2):20-3.
Luo M, Lim WY, Tan CS, Ning Y, Chia KS, van Dam RM, et al. Longitudinal trends in HbA1c and associations with comorbidity and all-cause mortality in Asian patients with Type 2 diabetics: A cohort study. Diabetes Res Clin Pract. 2017;133:69-77. PMid:28898713 DOI: https://doi.org/10.1016/j.diabres.2017.08.013
Hymowitz MB, Chang D, Feinberg EB, Roy S. Increased intraocular pressure and hyperglicemic level in diabetic patients. PLoS One. 2016;11(3):1-7. https://doi.org/10.1371/journal.pone.0151833 PMid:27002725 DOI: https://doi.org/10.1371/journal.pone.0151833
Jijeon S. Relationship between systemic vascular characteristic and RNFL loss in patients with Type2 diabetes. Sci Rep. 2018;8:10510. DOI: https://doi.org/10.1038/s41598-018-28985-8
Foster PJ, Broadway C, Yip JL, Hayat S, Luben R, Dalzell N, et al. Serum lipids and glycated haemoglobin are associated with intraocular pressure in European people. Investig Ophthalmol Vis Sci. 2010;51(13):5829.
Oshitari T, Fujimoto N, Hanawa K, Adachi-Usami E, Roy S. Effect of chronic hyperglycemia on intraocular pressure in patients with diabetes. Am J Ophthalmol. 2006;143(2):363-5. https://doi.org/10.1016/j.ajo.2006.09.033 PMid:17258539 DOI: https://doi.org/10.1016/j.ajo.2006.09.033
Zhao D, Cho J, Kim MH, Friedman DS, Guallar E. Diabetes, fasting glucose and the risk of glaucoma: A meta-analysis. AAO J. 2015;122(1):72-8. https://doi.org/10.1016/j.ophtha.2014.07.051 PMid:25283061 DOI: https://doi.org/10.1016/j.ophtha.2014.07.051
Lonneville YH, Ozdek SC, Onol M, Yetkin I, Gürelik G, Hasanreisoğlu B. The effect of blood glucose regulation on retinal nerve fiber layer thickness in diabetic patients. Ophthalmologica. 2003;217(5):347-50. https://doi.org/10.1159/000071350 PMid:12913325 DOI: https://doi.org/10.1159/000071350
Sacca SC, Pascotto A, Caicione P, Capris P, Izzotti A. Oxidative DNA damage in the human trabecular meshwork. Arch Ophthalmol. 2005;123(4):458-63. https://doi.org/10.1001/archopht.123.4.458 PMid:15824217 DOI: https://doi.org/10.1001/archopht.123.4.458
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Masitha Dewi Sari, Rina Amelia, Aryani A. Amra (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0